Clinical Trials Directory

Trials / Unknown

UnknownNCT01601353

Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Tissue Genesis · Industry
Sex
Male
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of adipose derived cells for the treatment of erectile dysfunction symptoms.

Detailed description

This trial is being conducted to determine the safety and efficacy of injecting autologous adipose derived cells into the penis of men with erectile dysfunction. Subjects will be randomized into a treatment and control arm.

Conditions

Interventions

TypeNameDescription
DEVICETissue Genesis Cell Isolation SystemLiposuction followed by injection of autologous adipose derived cells

Timeline

Start date
2012-05-01
Primary completion
2018-08-01
Completion
2021-08-01
First posted
2012-05-18
Last updated
2021-06-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01601353. Inclusion in this directory is not an endorsement.

Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symp (NCT01601353) · Clinical Trials Directory